Research Progress on the Relationship between Uterine Fibroids and Vitamin D

doi:10.12280/gjfckx.20210021

Abstract

Abstract:

Uterine fibroids are common benign tumors in gynecology, which seriously affect women′s quality of life. The current idea of clinical treatment of uterine fibroids is to formulate different conservative treatment plans or surgical treatment plans based on individual differences, but these treatment plans have drawbacks. For many years, the medical profession has been looking for better treatments for uterine fibroids, and the relationship between vitamin D and uterine fibroids has also been discovered. As a steroid compound, vitamin D plays an important role in various organs and tissues of the human body. The confirmed obstetrics and gynecology diseases related to vitamin D include infertility, polycystic ovary syndrome and premature delivery. Studies in the past decade have confirmed that reduced levels of vitamin D in the human body are one of the risk factors for the occurrence and development of uterine fibroids. Some current studies have also found that drug supplementation with vitamin D and its analogues can play a role in the treatment of uterine fibroids.

Key words: Vitamin D, Uterus, Myoma, Receptors,calcitriol, Drug therapy

WANG Zi-hao, ZHOU Jian-zheng, WANG Mei-yun, YANG Ling. Research Progress on the Relationship between Uterine Fibroids and Vitamin D[J]. Journal of International Obstetrics and Gynecology, 2021, 48(5): 543-547.

References 33

[1]	Stewart EA, Laughlin-Tommaso SK, Catherino WH, et al. Uterine fibroids[J]. Nat Rev Dis Primers, 2016,2:16043. doi: 10.1038/nrdp.2016.43. doi: 10.1038/nrdp.2016.43
[2]	De La Cruz MS, Buchanan EM. Uterine Fibroids: Diagnosis and Treatment[J]. Am Fam Physician, 2017,95(2):100-107.
[3]	Pavone D, Clemenza S, Sorbi F, et al. Epidemiology and Risk Factors of Uterine Fibroids[J]. Best Pract Res Clin Obstet Gynaecol, 2018,46:3-11. doi: 10.1016/j.bpobgyn.2017.09.004. doi: S1521-6934(17)30137-2 pmid: 29054502
[4]	Voulgaris N, Papanastasiou L, Piaditis G, et al. Vitamin D and aspects of female fertility[J]. Hormones(Athens), 2017,16(1):5-21. doi: 10.14310/horm.2002.1715. doi: 10.14310/horm.2002.1715
[5]	Arslan S, Akdevelioğlu Y. The Relationship Between Female Reproductive Functions and Vitamin D[J]. J Am Coll Nutr, 2018,37(6):546-551. doi: 10.1080/07315724.2018.1431160. doi: 10.1080/07315724.2018.1431160
[6]	Ciebiera M, Ali M, Zgliczyńska M, et al. Vitamins and Uterine Fibroids: Current Data on Pathophysiology and Possible Clinical Relevance[J]. Int J Mol Sci, 2020,21(15):5528. doi: 10.3390/ijms21155528. doi: 10.3390/ijms21155528
[7]	Mohammadi R, Tabrizi R, Hessami K, et al. Correlation of low serum vitamin-D with uterine leiomyoma: a systematic review and meta-analysis[J]. Reprod Biol Endocrinol, 2020,18(1):85. doi: 10.1186/s12958-020-00644-6. doi: 10.1186/s12958-020-00644-6
[8]	Islam MS, Ciavattini A, Petraglia F, et al. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics[J]. Hum Reprod Update, 2018,24(1):59-85. doi: 10.1093/humupd/dmx032. doi: 10.1093/humupd/dmx032
[9]	Jayes FL, Liu B, Feng L, et al. Evidence of biomechanical and collagen heterogeneity in uterine fibroids[J]. PLoS One, 2019,14(4):e0215646. doi: 10.1371/journal.pone.0215646. doi: 10.1371/journal.pone.0215646
[10]	Aleksandrovych V, Białas M, Pasternak A, et al. Identification of uterine telocytes and their architecture in leiomyoma[J]. Folia Med Cracov, 2018,58(3):89-102. doi: 10.24425/fmc.2018.125075. doi: 10.24425/fmc.2018.125075 pmid: 30521514
[11]	Baranov VS, Osinovskaya NS, Yarmolinskaya MI. Pathogenomics of Uterine Fibroids Development[J]. Int J Mol Sci, 2019,20(24):6151. doi: 10.3390/ijms20246151. doi: 10.3390/ijms20246151
[12]	El Andaloussi A, Al-Hendy A, Ismail N, et al. Introduction of Somatic Mutation in MED12 Induces Wnt4/β-Catenin and Disrupts Autophagy in Human Uterine Myometrial Cell[J]. Reprod Sci, 2020,27(3):823-832. doi: 10.1007/s43032-019-00084-7. doi: 10.1007/s43032-019-00084-7
[13]	Crabtree JS, Jelinsky SA, Harris HA, et al. Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway[J]. Cancer Res, 2009,69(15):6171-6178. doi: 10.1158/0008-5472.CAN-08-4471. doi: 10.1158/0008-5472.CAN-08-4471 pmid: 19622772
[14]	Al-Hendy A, Diamond MP, Boyer TG, et al. Vitamin D3 Inhibits Wnt/β-Catenin and mTOR Signaling Pathways in Human Uterine Fibroid Cells[J]. J Clin Endocrinol Metab, 2016,101(4):1542-1551. doi: 10.1210/jc.2015-3555. doi: 10.1210/jc.2015-3555 pmid: 26820714
[15]	Halder SK, Osteen KG, Al-Hendy A. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells[J]. Hum Reprod, 2013,28(9):2407-2416. doi: 10.1093/humrep/det265. doi: 10.1093/humrep/det265
[16]	Philips N, Samuel P, Keller T, et al. Beneficial Regulation of Cellular Oxidative Stress Effects, and Expression of Inflammatory, Angiogenic, and the Extracellular Matrix Remodeling Proteins by 1α,25-Dihydroxyvitamin D3 in a Melanoma Cell Line[J]. Molecules, 2020,25(5):1164. doi: 10.3390/molecules25051164. doi: 10.3390/molecules25051164
[17]	Ali M, Shahin SM, Sabri NA, et al. 1,25 Dihydroxyvitamin D3 Enhances the Antifibroid Effects of Ulipristal Acetate in Human Uterine Fibroids[J]. Reprod Sci, 2019,26(6):812-828. doi: 10.1177/1933719118812720. doi: 10.1177/1933719118812720
[18]	Ito I, Waku T, Aoki M, et al. A nonclassical vitamin D receptor pathway suppresses renal fibrosis[J]. J Clin Invest, 2013,123(11):4579-4594. doi: 10.1172/JCI67804. doi: 10.1172/JCI67804
[19]	Hemida MA, AbdElmoneim NA, Hewala TI, et al. Vitamin D Receptor in Breast Cancer Tissues and Its Relation to Estrogen Receptor Alpha (ER-α) Gene Expression and Serum 25-hydroxyvitamin D Levels in Egyptian Breast Cancer Patients: A Case-control Study[J]. Clin Breast Cancer, 2019,19(3):e407-e414. doi: 10.1016/j.clbc.2018.12.019. doi: 10.1016/j.clbc.2018.12.019
[20]	Ali M, Shahin SM, Sabri NA, et al. Hypovitaminosis D exacerbates the DNA damage load in human uterine fibroids, which is ameliorated by vitamin D3 treatment[J]. Acta Pharmacol Sin, 2019,40(7):957-970. doi: 10.1038/s41401-018-0184-6. doi: 10.1038/s41401-018-0184-6
[21]	Puchar A, Feyeux C, Luton D, et al. Therapeutic management of uterine fibroid tumors[J]. Minerva Ginecol, 2016,68(4):466-476. pmid: 26698838
[22]	Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future[J]. Hum Reprod Update, 2016,22(6):665-686. doi: 10.1093/humupd/dmw023. doi: 10.1093/humupd/dmw023
[23]	Donnez J, Donnez O, Matule D, et al. Long-term medical management of uterine fibroids with ulipristal acetate[J]. Fertil Steril, 2016,105(1):165- 173.e4. doi: 10.1016/j.fertnstert.2015.09.032. doi: 10.1016/j.fertnstert.2015.09.032
[24]	Middelkoop MA, Bet PM, Drenth JPH, et al. Risk-efficacy balance of ulipristal acetate compared to surgical alternatives[J]. Br J Clin Pharmacol, 2021,87(7):2685-2697. doi: 10.1111/bcp.14708. doi: 10.1111/bcp.14708 pmid: 33341097
[25]	Ciebiera M, Vitale SG, Ferrero S, et al. Vilaprisan, a New Selective Progesterone Receptor Modulator in Uterine Fibroid Pharmaco-therapy-Will it Really be a Breakthrough?[J]. Curr Pharm Des, 2020,26(3):300-309. doi: 10.2174/1381612826666200127092208. doi: 10.2174/1381612826666200127092208
[26]	Charoenngam N, Holick MF. Immunologic Effects of Vitamin D on Human Health and Disease[J]. Nutrients, 2020,12(7):2097. doi: 10.3390/nu12072097. doi: 10.3390/nu12072097
[27]	Bläuer M, Rovio PH, Ylikomi T, et al. Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro[J]. Fertil Steril, 2009,91(5):1919-1925. doi: 10.1016/j.fertnstert.2008.02.136. doi: 10.1016/j.fertnstert.2008.02.136 pmid: 18423458
[28]	Ciavattini A, Delli Carpini G, Serri M, et al. Hypovitaminosis D and "small burden" uterine fibroids: Opportunity for a vitamin D supplementation[J]. Medicine(Baltimore), 2016,95(52):e5698. doi: 10.1097/MD.0000000000005698. doi: 10.1097/MD.0000000000005698
[29]	Hajhashemi M, Ansari M, Haghollahi F, et al. The effect of vitamin D supplementation on the size of uterine leiomyoma in women with vitamin D deficiency[J]. Caspian J Intern Med, 2019,10(2):125-131. doi: 10.22088/cjim.10.2.125. doi: 10.22088/cjim.10.2.125 pmid: 31363390
[30]	Arjeh S, Darsareh F, Asl ZA, et al. Effect of oral consumption of vitamin D on uterine fibroids: A randomized clinical trial[J]. Complement Ther Clin Pract, 2020,39:101159. doi: 10.1016/j.ctcp.2020.101159. doi: 10.1016/j.ctcp.2020.101159
[31]	Corachán A, Ferrero H, Escrig J, et al. Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model[J]. Fertil Steril, 2020,113(1):205-216.e4. doi: 10.1016/j.fertnstert.2019.09.018. doi: 10.1016/j.fertnstert.2019.09.018
[32]	夏维波, 章振林, 林华, 等. 维生素D及其类似物临床应用共识[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018,11(1):1-19. doi: 10.3969/j.issn.1674-2591.2018.01.001. doi: 10.3969/j.issn.1674-2591.2018.01.001
[33]	Ciebiera M, Ali M, Prince L, et al. The Evolving Role of Natural Compounds in the Medical Treatment of Uterine Fibroids[J]. J Clin Med, 2020,9(5):1479. doi: 10.3390/jcm9051479. doi: 10.3390/jcm9051479